176 SUPPRESSION OF AUTOPHAGY ENHANCES PREFERENTIAL TOXICITY OF PACLITAXEL TO FOLLICULIN-DEFICIENT RENAL CANCER CELLS

Qi Zhang,Shuhui Si,Sue Schoen,Jin Xun-bo,Jindong Chen,Guan Wu

DOI: https://doi.org/10.1016/j.juro.2013.02.1556

IF: 7.6

2013-01-01

The Journal of Urology

Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research (I)1 Apr 2013176 SUPPRESSION OF AUTOPHAGY ENHANCES PREFERENTIAL TOXICITY OF PACLITAXEL TO FOLLICULIN-DEFICIENT RENAL CANCER CELLS Qi Zhang, Shuhui Si, Sue Schoen, Xunbo Jin, Jindong Chen, and Guan Wu Qi ZhangQi Zhang Rochester, NY More articles by this author , Shuhui SiShuhui Si Rochester, NY More articles by this author , Sue SchoenSue Schoen Rochester, NY More articles by this author , Xunbo JinXunbo Jin Jinan, China, People's Republic of More articles by this author , Jindong ChenJindong Chen Rochester, NY More articles by this author , and Guan WuGuan Wu Rochester, NY More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.1556AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Birt-Hogg-Dubé (BHD) syndrome, caused by loss-of-function mutations in folliculin (FLCN), is associated with increased risk of renal cell cancer (RCC) development. Paclitaxel, a widely used chemotherapeutic drug, can induce apoptosis in variety of cancer cells. Previous studies have shown preferential toxicity of paclitaxel to FLCN-deficient kidney cancer cell line, UOK257. In this report, we investigate the cellular and molecular mechanism of paclitaxel-induced autophagy and apoptosis in renal cancer cells with and without FLCN expression. METHODS Two human renal cancer cell line pairs, UOK257 (FLCN-) with its counterpart UOK257-2 (FLCN+) and ACHN 5968 (FLCN-) with ACHN-sc (FLCN+), were treated with paclitaxel and control vehicle. Cell viability was measured with MTT assay and cell viability counting assay. Apoptosis was evaluated by TUNEL assay and caspase-3 Western blot. Autophagy was measured by LC3-I/II protein level, monodansyl cadaverine (MDC) and GFP-LC3 assay. Activation of the MAPK pathway was investigated with p-MEK and p-ERK Western blot. Statistical differences were analyzed with ANOVA and paired Student t-test, p<0.05 was considered statistically significant. RESULTS After paclitaxel treatment, a dose-dependent decrease in cell viability and increase in apoptosis were observed in UOK257 and ACHN 5968 cells compared to their FLCN+ counterparts, suggesting that RCC cells without FLCN were more sensitive to paclitaxel. Enhanced autophagy was found to be associated with paclitaxel treatment in FLCN deficient RCC cells. The MAPK pathway was also identified as a key pathway for the activation of autophagy in these kidney cancer cells. Inhibition of phosphorylated ERK with an ERK inhibitor U0126 showed significant decrease in autophagy. Furthermore, when treated with paclitaxel and autophagy inhibitor, 3-Methyladenine (3-MA), apoptosis induced by paclitaxel was significantly increased in UOK257 and ACHN 5968 cells. CONCLUSIONS Preferential toxicity of paclitaxel to FLCN-deficient kidney cancer cells is associated with enhanced autophagy. Suppression of autophagy further enhances paclitaxel-induced apoptosis in FLCN-deficient renal cancer cells. Our results suggest that paclitaxel combined with autophagy inhibitor might be a more effective chemotherapeutic approach for FLCN-deficient renal cancer. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e72 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Qi Zhang Rochester, NY More articles by this author Shuhui Si Rochester, NY More articles by this author Sue Schoen Rochester, NY More articles by this author Xunbo Jin Jinan, China, People's Republic of More articles by this author Jindong Chen Rochester, NY More articles by this author Guan Wu Rochester, NY More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...